Cellect Biotechnology Ltd. Form 6-K Summary
Business Context and Reporting Period
This Form 6-K was filed by Cellect Biotechnology Ltd. on July 6, 2018, covering events occurring in July 2018. The registrant is a foreign private issuer based in Kfar Saba, Israel.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses on corporate governance events rather than financial performance.
Material Changes
On July 5, 2018, the Company reconvened its annual general meeting of shareholders. At this meeting, ordinary shareholders and ADS holders passed all agenda items as originally proposed. These items were previously described in Exhibit 99.1 of a Form 6-K filed on May 24, 2018.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for future guidance, management outlook, specific risks, contingencies, or unusual items beyond the successful conclusion of the shareholder meeting.
Key Facts for Investor Verification
- Verify the specific agenda items approved at the reconvened annual general meeting by reviewing Exhibit 99.1 of the May 24, 2018 Form 6-K.
- Confirm that all proposed resolutions were passed without dissent or amendment.
- Note that this filing does not contain updated financial statements or operational metrics.